Professor Amanj Kurdi
Strathclyde Institute of Pharmacy and Biomedical Sciences
Personal statement
Professor Amanj Kurdi is Professor of Pharmacoepidemiology and Pharmacy Practice at the 糖心视频. His research focuses on the generation and application of real world evidence to evaluate the utilisation, effectiveness, safety, and value of medicines and healthcare interventions, with the aim of informing clinical practice, health policy, and regulatory decision making.
His work spans pharmacoepidemiology, drug utilisation research, medicines optimisation, medication safety, antimicrobial stewardship, and health services research. He has extensive expertise in the analysis of large-scale routinely collected healthcare data, including linked electronic health records, prescribing databases, hospital datasets, and national population-level resources. Using advanced epidemiological, statistical, and data science methods, his research examines prescribing quality, medication adherence and persistence, treatment outcomes, and the impact of health policies and clinical guidelines across a range of therapeutic areas.
Professor Kurdi has particular interests in antimicrobial resistance (AMR), antimicrobial stewardship, cardiovascular disease, diabetes, biologics and specialist medicines, and the use of real world data to support post-marketing surveillance and medicines safety monitoring. He leads and collaborates on national and international projects involving big data analytics, health informatics, and population health research, working closely with healthcare providers, policymakers, regulators, and academic partners.
He actively collaborates with researchers and institutions across the UK and internationally and contributes to several multidisciplinary research networks and initiatives. Through his research, he aims to improve the quality, safety, and sustainability of healthcare while strengthening the evidence base that supports medicines use and health policy decisions.
Prize And Awards
- Recipient
- 1/6/2026
- Recipient
- 24/2/2025
- Recipient
- 16/11/2024
- Recipient
- 1/3/2024
- Recipient
- 11/2/2024
- Recipient
- 31/1/2024
Publications
- , Crearie Christine, , Pan Jiafeng, Sneden Fraser N, Martin David, , Thomson Catherine S, Clarke Julie,
- British Journal of Clinical Pharmacology (2026)
- Ahmed Hemn, Darweesh Omeed, Karim Gulbahar, Rashid Baref, Ahmed Rozhgar, Seaton Ronald Andrew, Godman Brian,
- JMIR Public Health and Surveillance (2026)
- Zheng Bang, , Amstutz Alain, Green Amelia, Herrett Emily, Tazare John, Wen Qing, Mahalingasivam Viyaasan, Smith Rebecca, MacKenna Brian, Mehrkar Amir, Bacon Sebastian, Goldacre Ben, , Sheikh Aziz, Tomlinson Laurie
- Nature Communications Vol 17 (2026)
- , Wall A, ,
- International Journal of Clinical Pharmacy (2026)
- Mousa Rimal, Hammad Eman, Melhem Samar, Balkhi Bander, , Massad Eman
- Health Policy and Technology Vol 15 (2026)
- Jeli膰 Ana Goli膰, Vu膷enovi膰 Valentina, Vu膷enovi膰 Sa拧a, Laki膰 Dragana, Markovi膰-Pekovi膰 Vanda, , Godman Brian, 艩krbi膰 Ranko
- Exploratory Research in Clinical and Social Pharmacy Vol 22 (2026)
Professional Activities
- Speaker
- 12/8/2026
- Organiser
- 17/6/2026
- Organiser
- 27/5/2026
- Organiser
- 29/4/2026
- Organiser
- 11/3/2026
- Participant
- 26/2/2026
Projects
- Kurdi, Amanj (Principal Investigator)
- 01-Jan-2026 - 31-Jan-2027
- Bennie, Marion (Principal Investigator) Kurdi, Amanj (Co-investigator) Mueller, Tanja (Co-investigator)
- 01-Jan-2025 - 30-Jan-2026
- Elrggal, Mahmoud (CoPI) Kurdi, Amanj (Principal Investigator)
- A 48 months project funded by The Saudi Basic Science Initiative, Research Development and Innovation Authority (RDIA), ~拢300K
- 01-Jan-2025 - 30-Jan-2029
- Alotaibi, Eman (Principal Investigator) Kurdi, Amanj (Principal Investigator) Alotaibi, Badriah (Academic)
- 01-Jan-2024 - 30-Jan-2025
- Dunlop, Emma (Co-investigator) Mueller, Tanja (Co-investigator) Bennie, Marion (Principal Investigator) Kurdi, Amanj (Co-investigator) Lu, Liya (Researcher) Kavanagh, Kimberley (Co-investigator)
- The aim of CMOP-PHS is to better understand the real world outcomes of cancer medicines for cancer patients in Scotland. The project is a collaboration between the 糖心视频, Public Health Scotland and the NHS Health Boards.
- 01-Jan-2024 - 31-Jan-2027
- Vettini, Amanda (Researcher) Dunlop, Emma (Co-investigator) Mueller, Tanja (Co-investigator) Bennie, Marion (Principal Investigator) Kurdi, Amanj (Co-investigator) Lu, Liya (Researcher)
- The aim of CMOP-PHS is to better understand the real world outcomes of cancer medicines for cancer patients in Scotland. The project is a collaboration between the 糖心视频, Public Health Scotland and the NHS Health Boards.
- 01-Jan-2024 - 31-Jan-2027
Contact
Professor
Amanj
Kurdi
Strathclyde Institute of Pharmacy and Biomedical Sciences
Email: amanj.baker@strath.ac.uk
Tel: 548 2181